Gina M. Mantia-Smaldone, MD, Joins Fox Chase Cancer Center as Gynecologic Oncology Surgeon

PHILADELPHIA, PA (July 25, 2013)—Gina M. Mantia-Smaldone, MD, has joined Fox Chase Cancer Center as a gynecologic oncology surgeon after completing fellowship training in the division of gynecologic oncology at the Hospital of the University of Pennsylvania. She specializes in treating patients with ovarian cancer and other gynecologic cancers.

After receiving her medical degree from the State University of New York at Stony Brook School of Medicine, Dr. Mantia-Smaldone completed a residency in obstetrics and gynecology at Magee-Womens Hospital of the University of Pittsburgh Medical Center. She continued as an attending physician there while completing a postdoctoral fellowship in ovarian cancer immunology within the division of gynecologic oncology at Magee-Womens Research Institute of the University of Pittsburgh before going on to begin her clinical fellowship.

Dr. Mantia-Smaldone’s research interests include the development of innovative therapeutics for ovarian cancer patients; BRCA mutations and hereditary ovarian cancer; and fertility and gynecologic cancers.

Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence six consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.

For more information, call 888-369-2427

Resize Text